EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Seasonality and pandemic-era trends in Stevens-Johnson syndrome and toxic epidermal necrolysis: A pharmacovigilance and time series analysis

Eric Milan Mukherjee, Dodie Park, Amir Asiaee, Matthew S Krantz, Cosby A Stone, Michelle Martin-Pozo, Elizabeth Phillips

Journal of Allergy and Clinical Immunology: Global · 2027-01 · 6 (1) · 100796

DOI: 10.1016/j.jacig.2026.100796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2027-01. Verfasst von Eric Milan Mukherjee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tenn. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, FIC NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Seasonal variation in adverse drug reactions may reflect changes in environmental exposures, prescribing, or host susceptibility.

Objective

We aimed to evaluate seasonality and pandemic-era trends in Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).

Methods

We performed a cross-sectional pharmacovigilance study of the US Food and Drug Administration Adverse Event Reporting System from 2010 to 2023. Primary seasonality analysis used Northern Hemisphere reports with complete event dates from 2010 to 2019. Time series models trained on prepandemic data were used to generate counterfactual forecasts through December 2023 and evaluate the impact of the coronavirus disease 2019 pandemic. Influenza, respiratory syncytial virus, and photosensitivity served as positive controls.

Results

Among 5,947 SJS/TEN reports, monthly and seasonal variation was not significant, and seasonality strength, assessed using seasonal-trend decomposition using locally estimated scatterplot smoothing, was low (0.163). In contrast, influenza, respiratory syncytial virus, and photosensitivity demonstrated robust seasonal patterns. During the pandemic, influenza and respiratory syncytial virus fell substantially below forecasts, whereas SJS/TEN reporting remained near or modestly above expected levels. The magnitude of the SJS/TEN deviation was sensitive to the prepandemic training interval, with progressively later training windows yielding smaller observed-to-expected differences. Primary-suspect drug composition also shifted, and immune checkpoint inhibitor involvement increased substantially over time.

Conclusion

SJS/TEN demonstrated minimal seasonality despite strong seasonality in positive controls. These findings support a limited role for seasonal environmental exposures relative to host susceptibility and drug-specific risk while highlighting the importance of evolving treatment patterns when interpreting pharmacovigilance trends. The increasing representation of immune checkpoint inhibitors in SJS/TEN reports further highlights the importance of evolving therapeutic landscapes when interpreting long-term pharmacovigilance trends.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Stevens-Johnson syndromeimmune checkpoint inhibitorspharmacovigilancetoxic epidermal necrolysis

Autor:innen und Institutionen

  • Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tenn.
  • Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tenn.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn.
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
  • Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia.

Förderung

  • NIAID NIH HHS
  • FIC NIH HHS
  • NIGMS NIH HHS
  • NHGRI NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • National Institute of Child Health and Human Development
  • National Institute of General Medical Sciences

Zitieren

APA

Mukherjee, E. M., Park, D., Asiaee, A., Krantz, M. S., Stone, C. A., Martin-Pozo, M., & Phillips, E. (2027). Seasonality and pandemic-era trends in Stevens-Johnson syndrome and toxic epidermal necrolysis: A pharmacovigilance and time series analysis. Journal of Allergy and Clinical Immunology: Global, 6(1), 100796. https://doi.org/10.1016/j.jacig.2026.100796

Vancouver

Mukherjee EM, Park D, Asiaee A, Krantz MS, Stone CA, Martin-Pozo M, et al. Seasonality and pandemic-era trends in Stevens-Johnson syndrome and toxic epidermal necrolysis: A pharmacovigilance and time series analysis. Journal of Allergy and Clinical Immunology: Global. 2027;6(1):100796. doi:10.1016/j.jacig.2026.100796

BibTeX
@article{Mukherjee2027,
  author = {Mukherjee, Eric Milan and Park, Dodie and Asiaee, Amir and Krantz, Matthew S and Stone, Cosby A and Martin-Pozo, Michelle and Phillips, Elizabeth},
  title = {Seasonality and pandemic-era trends in Stevens-Johnson syndrome and toxic epidermal necrolysis: A pharmacovigilance and time series analysis},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2027},
  volume = {6},
  number = {1},
  pages = {100796},
  doi = {10.1016/j.jacig.2026.100796}
}
Kostenlos starten →